UA26973A1 - Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів - Google Patents

Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів

Info

Publication number
UA26973A1
UA26973A1 UA4895539A UA4895539A UA26973A1 UA 26973 A1 UA26973 A1 UA 26973A1 UA 4895539 A UA4895539 A UA 4895539A UA 4895539 A UA4895539 A UA 4895539A UA 26973 A1 UA26973 A1 UA 26973A1
Authority
UA
Ukraine
Prior art keywords
peroxides
glycoproteinconnected
coused
prophylaxis
agent
Prior art date
Application number
UA4895539A
Other languages
English (en)
Russian (ru)
Inventor
Вернер ШHАЙДЕР
Брітта МЕЙЕР
Еріх Ф. ЕЛЬСТHЕР
Original Assignee
Штайгервальд Арцнайміттельверк Гмбх
Штайгервальд Арцнаймиттельверк Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Штайгервальд Арцнайміттельверк Гмбх, Штайгервальд Арцнаймиттельверк Гмбх filed Critical Штайгервальд Арцнайміттельверк Гмбх
Publication of UA26973A1 publication Critical patent/UA26973A1/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Винахід стосується застосування магній-піридоксаль-5'-фосфат-глютамінату для попередження хвороб, викликаних LDL-зв'язаними пероксидами і які призводять до пошкодження судин. За необхідності лікарська сполука може містити марганцеву сіль.
UA4895539A 1990-05-25 1991-05-24 Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів UA26973A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (de) 1990-05-25 1990-05-25 Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben

Publications (1)

Publication Number Publication Date
UA26973A1 true UA26973A1 (uk) 2000-02-28

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4895539A UA26973A1 (uk) 1990-05-25 1991-05-24 Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів

Country Status (28)

Country Link
US (1) US5372999A (uk)
EP (1) EP0458287B1 (uk)
JP (1) JPH07119174B2 (uk)
KR (1) KR970005180B1 (uk)
CN (1) CN1050750C (uk)
AT (1) ATE142884T1 (uk)
AU (1) AU651108B2 (uk)
CA (1) CA2043228C (uk)
CZ (1) CZ280683B6 (uk)
DE (2) DE4016963A1 (uk)
DK (1) DK0458287T3 (uk)
EG (1) EG19730A (uk)
ES (1) ES2091262T3 (uk)
GR (1) GR3021077T3 (uk)
HR (1) HRP931445B1 (uk)
HU (1) HU219223B (uk)
IE (1) IE76728B1 (uk)
IL (1) IL98156A (uk)
IN (1) IN173057B (uk)
LT (1) LT3335B (uk)
LV (1) LV10046B (uk)
MD (1) MD306C2 (uk)
MX (1) MX171883B (uk)
RU (1) RU2041713C1 (uk)
SI (1) SI9110925A (uk)
SK (1) SK278896B6 (uk)
UA (1) UA26973A1 (uk)
ZA (1) ZA913692B (uk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (de) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
CA2383252A1 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
AU2005304220A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2680801A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule
RU2484843C1 (ru) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (uk)
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker

Also Published As

Publication number Publication date
GR3021077T3 (en) 1996-12-31
HU911756D0 (en) 1991-12-30
LT3335B (en) 1995-07-25
LV10046A (lv) 1994-05-10
LTIP580A (en) 1994-12-27
DE69122170T2 (de) 1997-02-20
EP0458287A2 (en) 1991-11-27
CS156391A3 (en) 1992-02-19
AU7730191A (en) 1991-11-28
JPH07119174B2 (ja) 1995-12-20
KR910019616A (ko) 1991-12-19
KR970005180B1 (ko) 1997-04-14
ES2091262T3 (es) 1996-11-01
RU2041713C1 (ru) 1995-08-20
HRP931445B1 (en) 2000-04-30
MD306B1 (ro) 1995-10-31
CZ280683B6 (cs) 1996-04-17
MX171883B (es) 1993-11-22
ZA913692B (en) 1992-02-26
IE911783A1 (en) 1991-12-04
US5372999A (en) 1994-12-13
EP0458287B1 (en) 1996-09-18
CA2043228A1 (en) 1991-11-26
IN173057B (uk) 1994-02-05
CA2043228C (en) 1998-07-14
DE4016963C2 (uk) 1992-04-30
IL98156A0 (en) 1992-06-21
EG19730A (en) 1996-01-31
DE69122170D1 (de) 1996-10-24
LV10046B (en) 1995-02-20
SI9110925A (sl) 1998-06-30
CN1050750C (zh) 2000-03-29
CN1057391A (zh) 1992-01-01
MD306C2 (ro) 1996-02-29
HU219223B (en) 2001-03-28
IE76728B1 (en) 1997-11-05
DK0458287T3 (da) 1996-10-07
JPH04235130A (ja) 1992-08-24
DE4016963A1 (de) 1991-11-28
HUT58204A (en) 1992-02-28
SK278896B6 (sk) 1998-04-08
HRP931445A2 (en) 1996-02-29
EP0458287A3 (en) 1992-04-08
AU651108B2 (en) 1994-07-14
IL98156A (en) 1996-06-18
ATE142884T1 (de) 1996-10-15

Similar Documents

Publication Publication Date Title
UA26973A1 (uk) Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
GR980100096A (el) Νεα συνθεση βαλσαλαζιδης
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
AP9200355A0 (en) "Therapeutic agent"
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
CA2065889A1 (en) Increasing the choroidal blood flow
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease
IL106064A0 (en) Gallium complexes for the treatment of free radicalinduced diseases
AU1067795A (en) Use of lithium compounds in the treatment and prevention of alzheimer's disease
GR77250B (uk)
ZA884266B (en) Agents for the prevention of ranking fights in pigs
IT210223Z2 (it) Distribuzione libero o a moneta di assorbenti per l'igiene intima femminile.
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ZA941921B (en) Compositions for the treatment of eye diseases
IE871856L (en) "modified tissue plasminogen activator"
GB9109887D0 (en) Pharmaceutical formulations for the treatment of peripheral vascular diseases
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention
UA9481A (uk) Засіб для профілактики і лікування вільнорадикального пошкодження органів і тканин
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi